JP2005139120A - Method for producing dibenzothiepin derivative - Google Patents

Method for producing dibenzothiepin derivative Download PDF

Info

Publication number
JP2005139120A
JP2005139120A JP2003377810A JP2003377810A JP2005139120A JP 2005139120 A JP2005139120 A JP 2005139120A JP 2003377810 A JP2003377810 A JP 2003377810A JP 2003377810 A JP2003377810 A JP 2003377810A JP 2005139120 A JP2005139120 A JP 2005139120A
Authority
JP
Japan
Prior art keywords
compound
formula
added
reaction
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003377810A
Other languages
Japanese (ja)
Inventor
Yoshitaka Nakada
嘉孝 中田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ohara Pharmaceutical Co Ltd
Original Assignee
Ohara Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ohara Pharmaceutical Co Ltd filed Critical Ohara Pharmaceutical Co Ltd
Priority to JP2003377810A priority Critical patent/JP2005139120A/en
Publication of JP2005139120A publication Critical patent/JP2005139120A/en
Pending legal-status Critical Current

Links

Landscapes

  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a method for industrially advantageously producing zaltoprofen as an anti-inflammatory/analgesic agent. <P>SOLUTION: The method comprises the following process: Zinc iodide, sodium cyanide or potassium cyanide, and trimethylsilyl chloride are added to a compound of formula(I) followed by mixing them together to carry out a reaction to form a compound of formula(II). Sodium cyanide or potassium cyanide, trimethylsilyl chloride, acetonitrile and water are added to the compound of formula(II) followed by mixing them together to carry out a reaction to form a compound of formula(III). Polyphosphoric acid is made to act on the compound of formula(III) to effect cyclization, followed by addition of water to form a compound of formula(IV), which is then hydrolyzed to obtain the objective compound(zaltoprofen) of formula(V). In the above formulas, R is a lower alkyl. <P>COPYRIGHT: (C)2005,JPO&NCIPI

Description

本発明は、プロピオン酸系消炎鎮痛薬として有用な、下記の式(V)で表されるジベンゾチエピン誘導体(一般名称:ザルトプロフェン)の製法に関する。

Figure 2005139120
The present invention relates to a method for producing a dibenzothiepine derivative (generic name: zaltoprofen) represented by the following formula (V), which is useful as a propionic acid-based anti-inflammatory analgesic.
Figure 2005139120

式(V)の化合物の製法は種々提案されているが、何れの方法も出発原料から目的化合物に至るまで、多くの反応工程を必要とする。その中で有力な方法の一例を示せば、下記の如くである。

Figure 2005139120
(式中、Xはハロゲン原子を表す。)
すなわち上記方法は、式(I)の化合物を還元して式(VI)の化合物とし、これをハロゲン化反応に付して式(VII)の化合物に変え、次いでシアン化反応に付して式(III)の化合物とし、さらに2段階の加水分解反応に付して目的の式(V)の化合物とする方法である。
しかし、この方法も工程数が多く、工業的に有利な方法とは言い難い。 Various methods for producing the compound of formula (V) have been proposed, but each method requires many reaction steps from the starting material to the target compound. An example of a promising method among them is as follows.
Figure 2005139120
(In the formula, X represents a halogen atom.)
That is, in the above method, a compound of formula (I) is reduced to a compound of formula (VI), which is subjected to a halogenation reaction to give a compound of formula (VII), and then subjected to a cyanation reaction. In this method, the compound of (III) is further subjected to a two-stage hydrolysis reaction to obtain the desired compound of formula (V).
However, this method also has a large number of steps, and is not an industrially advantageous method.

特開昭61−050961号公報JP-A-61-050961 特開昭57−171961号公報JP-A-57-171961 特開昭55−532822号公報Japanese Patent Laid-Open No. 55-532822

本発明の課題は、反応工程数を少なくすることによって、工業的に有利な式(V)の化合物、すなわちザルトプロフェンの製法を提供することにある。 An object of the present invention is to provide an industrially advantageous method for producing a compound of formula (V), that is, zaltoprofen, by reducing the number of reaction steps.

本発明者は、前記課題を解決するため鋭意検討した結果、前記式(I)の化合物から3工程を経て式(III)の化合物とするところを、2工程で式(III)の化合物を好収率で得る方法を見出し、さらに検討を加え、本発明を完成することができた。   As a result of intensive studies to solve the above problems, the present inventor prefers that the compound of formula (III) is converted into the compound of formula (III) through three steps from the compound of formula (I) in two steps. A method for obtaining the yield was found, and further studies were made, and the present invention was completed.

すなわち本発明によれば、
(1)下記式(I)

Figure 2005139120
(式中、Rは低級アルキル基を示す。)の化合物に、ヨウ化亜鉛、シアン化ナトリウム又はシアン化カリウム、及びトリメチルシリルクロライドを加え、混合、反応させて下記式(II)
Figure 2005139120
(式中、Rは低級アルキル基を表す。)の化合物とし、式(II)の化合物に、ヨウ化ナトリウム又はヨウ化カリウム、トリメチルシリルクロライド、アセトニトリル及び水を加え、混合、反応させて下記式(III)
Figure 2005139120
(式中、Rは低級アルキル基を示す。)の化合物を得、式(III)の化合物にポリリン酸を作用させて閉環させた後、水を加えて下記式(IV)
Figure 2005139120
の化合物とし、さらに加水分解して下記式(V)の化合物を得る方法、
Figure 2005139120
(2)Rがメチル基又はエチル基である前記(1)に記載の方法
を提供することができる。 That is, according to the present invention,
(1) The following formula (I)
Figure 2005139120
To the compound (wherein R represents a lower alkyl group), zinc iodide, sodium cyanide or potassium cyanide, and trimethylsilyl chloride are added, mixed and reacted to form the following formula (II):
Figure 2005139120
(Wherein R represents a lower alkyl group), sodium iodide or potassium iodide, trimethylsilyl chloride, acetonitrile and water are added to the compound of formula (II), mixed and reacted to form the following formula ( III)
Figure 2005139120
(Wherein R represents a lower alkyl group), a compound of formula (III) was allowed to react with polyphosphoric acid to cyclize, and then water was added thereto to add the following formula (IV)
Figure 2005139120
A compound obtained by further hydrolysis to obtain a compound of the following formula (V):
Figure 2005139120
(2) The method according to (1) above, wherein R is a methyl group or an ethyl group.

本発明によれば、消炎鎮痛剤ザルトプロフェンの製造に際し、従来の方法より反応工程数が1工程短縮され、収率の向上のみならず作業効率上の利点がある。   According to the present invention, in producing the anti-inflammatory analgesic agent zaltoprofen, the number of reaction steps is shortened by one step compared with the conventional method, and there is an advantage not only in yield improvement but also in work efficiency.

本発明において、式(I)の化合物に、ヨウ化亜鉛、シアン化ナトリウム又はシアン化カリウム、及びトリメチルシリルクロライドを加え、混合、反応させる場合、通常、溶媒中で行われる。その溶媒としては、例えばアセトニトリル、テトラヒドロフラン、ジオキサン、塩化メチレン、クロロホルム、N,N−ジメチルホルムアミド、ジメチルスルホキシド等が挙げられるが、好ましくはアセトニトリルである。 この反応において使用する試薬の量は、式(I)の化合物に対してヨウ化亜鉛を触媒量程度、シアン化ナトリウム又はシアン化カリウムを1〜10倍モル、トリメチルシリルクロライドを1〜6倍モルの範囲内で使用すればよい。
反応は、通常、温和な条件下で行う。例えば40〜80℃で1〜48時間行うのが好ましい。
In the present invention, when zinc iodide, sodium cyanide or potassium cyanide, and trimethylsilyl chloride are added to the compound of formula (I) and mixed and reacted, the reaction is usually carried out in a solvent. Examples of the solvent include acetonitrile, tetrahydrofuran, dioxane, methylene chloride, chloroform, N, N-dimethylformamide, dimethyl sulfoxide, and the like, and acetonitrile is preferred. The amount of the reagent used in this reaction is within the range of a catalytic amount of zinc iodide, 1 to 10 times mol of sodium cyanide or potassium cyanide, and 1 to 6 times mol of trimethylsilyl chloride with respect to the compound of formula (I). Can be used.
The reaction is usually carried out under mild conditions. For example, it is preferably performed at 40 to 80 ° C. for 1 to 48 hours.

本発明において、式(II)の化合物に、ヨウ化ナトリウム又はヨウ化カリウム、トリメチルシリルクロリド、アセトニトリル及び水を加え、混合、反応させる場合、通常、溶媒中で行われる。その溶媒としては、例えばn−ヘキサン、シクロヘキサン、アセトニトリル、トルエン、テトラヒドロフラン、ジオキサン、塩化メチレン、クロロホルム等が挙げられ、中でもn−ヘキサン若しくはn−ヘキサンとアセトニトリルとの混合溶媒が好ましい。
この反応において使用する試薬の量は、式(II)の化合物に対してヨウ化ナトリウム又はヨウ化カリウムを2〜10倍モル、トリメチルシリルクロライドを2〜10倍モル及び水を1〜3倍モルの範囲内で使用し、アセトにトリルを2倍モル以上、好ましくは5〜7倍モル程度使用すればよい。
反応は、通常、温和な条件下で行う。例えば0〜40℃で1〜36時間行うのが好ましい。
In the present invention, sodium iodide or potassium iodide, trimethylsilyl chloride, acetonitrile and water are added to the compound of the formula (II), mixed and reacted, usually in a solvent. Examples of the solvent include n-hexane, cyclohexane, acetonitrile, toluene, tetrahydrofuran, dioxane, methylene chloride, chloroform, and the like. Among them, n-hexane or a mixed solvent of n-hexane and acetonitrile is preferable.
The amount of the reagent used in this reaction is 2 to 10 times mol of sodium iodide or potassium iodide, 2 to 10 times mol of trimethylsilyl chloride and 1 to 3 times mol of water with respect to the compound of formula (II). It may be used within the range, and tolyl may be used in an amount of at least 2 times mol, preferably about 5 to 7 times mol in aceto.
The reaction is usually carried out under mild conditions. For example, it is preferably performed at 0 to 40 ° C. for 1 to 36 hours.

本発明において、式(III)の化合物にポリリン酸を作用させて閉環させ、さらに加水分解する際は、式(III)の化合物に対してポリリン酸を5〜20倍重量程度、水を大過剰に使用するのが好ましい。
その閉環反応は、通常、70〜110℃で1〜10時間程度、加水分解反応は40〜80℃で0.5〜5時間程度行うのが好ましい。
In the present invention, polyphosphoric acid is allowed to act on the compound of formula (III) to cyclize it, and when hydrolyzed, polyphosphoric acid is about 5 to 20 times the weight of the compound of formula (III), and water is excessively large. It is preferable to use for.
The ring closure reaction is usually preferably carried out at 70 to 110 ° C. for about 1 to 10 hours, and the hydrolysis reaction at 40 to 80 ° C. for about 0.5 to 5 hours.

本発明において、式(IV)の化合物を加水分解して式(V)の化合物とする方法は、特に困難はなく、アミド化合物を加水分解してカルボン酸とする場合の一般的な方法に従えばよい。   In the present invention, the method of hydrolyzing the compound of formula (IV) to obtain the compound of formula (V) is not particularly difficult, and a general method in the case of hydrolyzing the amide compound to obtain carboxylic acid is followed. That's fine.

(1)5−アセチル−2−フェニルチオフェニル酢酸メチルエステル24g(0.08モル)にアセトニトリル120mlを加え、さらにシアン化ナトリウム11.76g(0.24モル)及びヨウ化亜鉛1.3gを加えた。この混合溶液にトリメチルシリルクロライド14g(0.13モル)を添加した後、加熱して緩やかに還流させながら36時間撹拌した。次いで反応溶液を室温まで放冷し、10%炭酸水素ナトリウム水溶液200mlに加え、トルエン300mlで有機物を抽出した。水層はトルエン100mlでさらに抽出し、先のトルエン層と合せ、水洗、乾燥後、溶媒を減圧留去して、油状の5−(1−シアノ−1−トリメチルシリルオキシエチル)−2−フェニルチオフェニル酢酸メチルエステル32g(高速液体クロマトグラフィーによる面積百分率93%;換算収率93%)を得た。 (1) Add 120 ml of acetonitrile to 24 g (0.08 mol) of 5-acetyl-2-phenylthiophenylacetic acid methyl ester, and further add 11.76 g (0.24 mol) of sodium cyanide and 1.3 g of zinc iodide. It was. After adding 14 g (0.13 mol) of trimethylsilyl chloride to this mixed solution, it was stirred for 36 hours while heating and gently refluxing. Next, the reaction solution was allowed to cool to room temperature, added to 200 ml of a 10% aqueous sodium hydrogen carbonate solution, and organic substances were extracted with 300 ml of toluene. The aqueous layer was further extracted with 100 ml of toluene, combined with the previous toluene layer, washed with water and dried, and then the solvent was distilled off under reduced pressure to give oily 5- (1-cyano-1-trimethylsilyloxyethyl) -2-phenylthio. 32 g of phenylacetic acid methyl ester (area percentage by high performance liquid chromatography 93%; conversion yield 93%) was obtained.

(2)油状の5−(1−シアノ−1−トリメチルシリルオキシエチル)−2−フェニルチオフェニル酢酸メチルエステル16g(換算モル:0.037モル)をn−ヘキサン50mlに溶解し、氷冷撹拌下、ヨウ化ナトリウム36g(0.24モル)、トリメチルシリルクロライド26g(0.24モル)及びアセトニトリル10g(0.24モル)を順次加えた。さらに水1.44g(0.08モル)を加え、室温で18時間撹拌した。この反応溶液にトルエン150mlを加えて撹拌した後、40%チオ硫酸ナトリウム水溶液100mlを加え、暫時撹拌して放置し、トルエン層を分取した。水層はトルエン50mlで再抽出し、先のトルエン層と合せて水洗、乾燥後、溶媒を減圧留去した。残渣に酢酸エチル60mlを加え、活性炭処理した後、溶媒を減圧留去して、油状の5−(1−シアノエチル)−2−フェニルチオフェニル酢酸メチルエステル12g(高速液体クロマトグラフィーによる面積百分率87%;換算収率91%)を得た。 (2) 16 g of oily 5- (1-cyano-1-trimethylsilyloxyethyl) -2-phenylthiophenylacetic acid methyl ester (converted mole: 0.037 mol) was dissolved in 50 ml of n-hexane, and the mixture was stirred under ice cooling. Then, 36 g (0.24 mol) of sodium iodide, 26 g (0.24 mol) of trimethylsilyl chloride and 10 g (0.24 mol) of acetonitrile were sequentially added. Further, 1.44 g (0.08 mol) of water was added and stirred at room temperature for 18 hours. To this reaction solution, 150 ml of toluene was added and stirred, and then 100 ml of 40% aqueous sodium thiosulfate solution was added and left stirring for a while to separate the toluene layer. The aqueous layer was re-extracted with 50 ml of toluene, washed with water together with the previous toluene layer, dried, and then the solvent was distilled off under reduced pressure. After adding 60 ml of ethyl acetate to the residue and treating with activated carbon, the solvent was distilled off under reduced pressure to give 12 g of oily methyl 5- (1-cyanoethyl) -2-phenylthiophenylacetic acid (area percentage 87% by high performance liquid chromatography). Converted yield 91%).

IRν max cm‐1 (film):2242(CN),1737(C=O)
H−NMR1NMR(CDCl)δ(ppm):1.62(3H,d,C−CH),3.61(3H,s,O−CH ),3.82(2H,s,CH),3.85(1H,m,CH),7.1〜7.4(8H,m,Ar−H)
13C−NMR1NMR(CDCl)δ(ppm):22(CH),31(CH),40(CH),52(CH),127〜135(Ar)
IRν max cm −1 (film): 2242 (CN), 1737 (C═O)
1 H-NMR 1 NMR (CDCl 3 ) δ (ppm): 1.62 (3H, d, C—CH 3 ), 3.61 (3H, s, O—CH 3 ), 3.82 (2H, s, CH 2 ), 3.85 (1H, m, CH), 7.1-7.4 (8H, m, Ar-H)
13 C-NMR 1 NMR (CDCl 3 ) δ (ppm): 22 (CH 3 ), 31 (CH), 40 (CH 2 ), 52 (CH 3 ), 127 to 135 (Ar)

(3)油状の5−(1−シアノエチル)−2−フェニルチオフェニル酢酸メチルエステル12g(換算モル:0.034モル)にポリリン酸120gを加え、加熱し反応温度を約95℃に保って3.5時間撹拌した。放冷後、氷水200ml及び2−プロパノール50mlを加え、この混合物を加温下約60℃に保って1時間撹拌した。放冷後、析出した結晶を濾取し、2−プロパノールと水の混合液で洗浄後、乾燥して、淡黄褐色結晶の2−(10,11−ジヒドロ−10−オキソベンゾ[b,f]チエピン−2−イル)プロピオンアミド9.5g(高速液体クロマトグラフィーによる面積百分率93%;換算収率89%)を得た。 (3) 120 g of polyphosphoric acid is added to 12 g of oily 5- (1-cyanoethyl) -2-phenylthiophenylacetic acid methyl ester (equivalent mol: 0.034 mol) and heated to maintain the reaction temperature at about 95 ° C. Stir for 5 hours. After allowing to cool, 200 ml of ice water and 50 ml of 2-propanol were added, and this mixture was kept at about 60 ° C. under heating and stirred for 1 hour. After allowing to cool, the precipitated crystals are collected by filtration, washed with a mixed solution of 2-propanol and water, dried, and dried to give pale tan crystals of 2- (10,11-dihydro-10-oxobenzo [b, f]. 9.5 g (thiepin-2-yl) propionamide (area percentage by high performance liquid chromatography 93%; conversion yield 89%) was obtained.

H−NMR1NMR(DMSO−d)δ(ppm):1.29(3H,d,C−CH),3.60(1H,q,CH),4.24(2H,s,CH),6.9〜8.1(9H,m,Ar−H,CONH
13C−NMR1NMR(DMSO−d)δ(ppm):19(CH),45(CH),51(CH),127〜146(Ar),176(CONH),192(CO)
1 H-NMR 1 NMR (DMSO-d 6 ) δ (ppm): 1.29 (3H, d, C—CH 3 ), 3.60 (1H, q, CH), 4.24 (2H, s, CH 2 ), 6.9~8.1 (9H, m, Ar-H, CONH 2)
13 C-NMR 1 NMR (DMSO-d 6 ) δ (ppm): 19 (CH 3 ), 45 (CH), 51 (CH 2 ), 127 to 146 (Ar), 176 (CONH 2 ), 192 (CO)

(4)淡黄褐色結晶の2−(10,11−ジヒドロ−10−オキソベンゾ[b,f]チエピン−2−イル)プロピオンアミド3g(換算モル:0.009モル)に水酸化カリウム6.6g(0.12モル)を水26mlに溶解した溶液とメタノール15mlを加え、加熱して前記結晶を溶解後、メタノールを常圧で留去し、加熱還流下、8時間撹拌した。次いで反応液を氷浴で冷却、撹拌下、6N塩酸水溶液で中和し、酢酸エチル50mlを加え、さらに6N塩酸でpH2に調整した。この混合液を暫時撹拌後、酢酸エチル層を分取し、水洗、乾燥し、溶媒を減圧留去した。残渣に酢酸エチル8mlを加え、析出した結晶を濾取し、n−ヘプタンで洗浄後、乾燥して、淡黄白色結晶の2−(10,11−ジヒドロ−10−オキソベンゾ[b,f]チエピン−2−イル)プロピオン酸1.7g(高速液体クロマトグラフィーによる面積百分率99%;換算収率60%)を得た。 (4) 3- (10,11-dihydro-10-oxobenzo [b, f] thiepin-2-yl) propionamide 3 g (converted mol: 0.009 mol) of pale tan crystals to 6.6 g of potassium hydroxide A solution prepared by dissolving (0.12 mol) in 26 ml of water and 15 ml of methanol were added and heated to dissolve the crystals. Then, the methanol was distilled off at normal pressure, and the mixture was stirred for 8 hours while heating under reflux. The reaction mixture was then cooled in an ice bath, neutralized with 6N aqueous hydrochloric acid with stirring, 50 ml of ethyl acetate was added, and the pH was adjusted to 2 with 6N hydrochloric acid. After stirring this mixture for a while, the ethyl acetate layer was separated, washed with water and dried, and the solvent was distilled off under reduced pressure. To the residue was added 8 ml of ethyl acetate, and the precipitated crystals were collected by filtration, washed with n-heptane, dried, and pale yellowish white crystals of 2- (10,11-dihydro-10-oxobenzo [b, f] thiepine. -2-yl) propionic acid 1.7g (area percentage 99% by high performance liquid chromatography; conversion yield 60%) was obtained.

H−NMR1NMR(CDCl)δ(ppm):1.48(3H,d,C−CH),3.72(1H,q,CH),4.35(2H,s,CH),7.1〜8.2(7H,m,Ar−H)
13C−NMR1NMR(CDCl)δ(ppm):19(CH),45(CH),51(CH),126〜142(Ar),180(COOH),192(CO)
MASS m/z:298(M
1 H-NMR 1 NMR (CDCl 3 ) δ (ppm): 1.48 (3H, d, C—CH 3 ), 3.72 (1H, q, CH), 4.35 (2H, s, CH 2 ), 7.1-8.2 (7H, m, Ar-H)
13 C-NMR 1 NMR (CDCl 3 ) δ (ppm): 19 (CH 3 ), 45 (CH), 51 (CH 2 ), 126 to 142 (Ar), 180 (COOH), 192 (CO)
MASS m / z: 298 (M + )

本発明によれば、消炎鎮痛薬ザルトプロフェンを従来より短い工程で製造することができるので、その工業的に有利な製造方法として利用することができる。   According to the present invention, since the anti-inflammatory analgesic agent zaltoprofen can be produced in a shorter process than before, it can be used as an industrially advantageous production method.

Claims (2)

下記式(I)
Figure 2005139120
(式中、Rは低級アルキル基を示す。)の化合物に、ヨウ化亜鉛、シアン化ナトリウム又はシアン化カリウム、及びトリメチルシリルクロライドを加え、混合、反応させて下記式(II)
Figure 2005139120
(式中、Rは低級アルキル基を表す。)の化合物とし、式(II)の化合物に、ヨウ化ナトリウム又はヨウ化カリウム、トリメチルシリルクロリド、アセトニトリル及び水を加え、混合、反応させて下記式(III)
Figure 2005139120
(式中、Rは低級アルキル基を示す。)の化合物を得、式(III)の化合物にポリリン酸を作用させて閉環させた後、水を加えて下記式(IV)
Figure 2005139120
の化合物とし、さらに加水分解して下記式(V)の化合物を得る方法。
Figure 2005139120
Formula (I)
Figure 2005139120
To the compound (wherein R represents a lower alkyl group), zinc iodide, sodium cyanide or potassium cyanide, and trimethylsilyl chloride are added, mixed and reacted to form the following formula (II):
Figure 2005139120
(Wherein R represents a lower alkyl group), sodium iodide or potassium iodide, trimethylsilyl chloride, acetonitrile and water are added to the compound of formula (II), mixed and reacted to form the following formula ( III)
Figure 2005139120
(Wherein R represents a lower alkyl group), a compound of formula (III) was allowed to react with polyphosphoric acid to cyclize, and then water was added thereto to add the following formula (IV)
Figure 2005139120
And further hydrolyzing to obtain a compound of the following formula (V).
Figure 2005139120
Rがメチル基又はエチル基である請求項1記載の方法。 The method according to claim 1, wherein R is a methyl group or an ethyl group.
JP2003377810A 2003-11-07 2003-11-07 Method for producing dibenzothiepin derivative Pending JP2005139120A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003377810A JP2005139120A (en) 2003-11-07 2003-11-07 Method for producing dibenzothiepin derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003377810A JP2005139120A (en) 2003-11-07 2003-11-07 Method for producing dibenzothiepin derivative

Publications (1)

Publication Number Publication Date
JP2005139120A true JP2005139120A (en) 2005-06-02

Family

ID=34688392

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003377810A Pending JP2005139120A (en) 2003-11-07 2003-11-07 Method for producing dibenzothiepin derivative

Country Status (1)

Country Link
JP (1) JP2005139120A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101219504B1 (en) 2005-08-24 2013-01-14 코오롱생명과학 주식회사 The Preparation Method of Dibenzothiepin Derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101219504B1 (en) 2005-08-24 2013-01-14 코오롱생명과학 주식회사 The Preparation Method of Dibenzothiepin Derivatives

Similar Documents

Publication Publication Date Title
JP2004518737A (en) Method for producing 2- (4-chlorobenzoylamino) -3- [2 (1H) -quinollinon-4-yl] propionic acid
JPH0489464A (en) Production of methoxyiminoacetamide compound and intermediate used therein
EP2044021A1 (en) Process for preparing remifentanil, intermediates thereof, use of said intermediates and processes for their preparation
JP2003519691A (en) Method for producing 5-cyanophthalide
JP2004524260A (en) Improved method for producing simvastatin
JP2005139120A (en) Method for producing dibenzothiepin derivative
JP4512100B2 (en) Process for producing substituted benzopyran compounds
JP2769058B2 (en) Preparation of cyclopropane derivatives
JPS5821626B2 (en) The best way to get started
HU214086B (en) Process for producing 3-isoxazolecarboxylic acid and intermediates thereof
JPH06340623A (en) Production of benzylsuccinic acid derivative and intermediate for its synthesis
JP2801647B2 (en) Method for producing 6-fluorochromone-2-carboxylic acid derivative
JPH07267950A (en) Production of 5-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-2,1,3-benzothiadiazole-4-amine or its acid-added salt
KR100466797B1 (en) Benzoazepin derivatives and process for production thereof using indium
JP2002512210A (en) Method for producing 2-hydroxyalkylhalophenone
KR101219504B1 (en) The Preparation Method of Dibenzothiepin Derivatives
JP3953141B2 (en) Process for producing 5-methyl-1,4-benzodioxan-6-carboxylic acids and novel intermediates thereof
JP3961049B2 (en) 3-Amino-4- (1-hydroxyalkyl) pyrazoline compound, method for producing the same and method for producing the same
KR20070011824A (en) Process for preparing dibenzothiepin derivatives and intermediates thereof
CN1290247A (en) Process and intermediates useful to make antifolates
JPWO2011065351A1 (en) Method for producing cyclohexane derivative
JPH07215968A (en) Method for producing azelastine
JPH10139724A (en) Production of 4-biphenylylacetic acid
JPS5915919B2 (en) Method for producing (N-methylpyryl-2)acetothioamide derivative
JPH0584301B2 (en)